Visi바카라 잘하는 법 for 2031
Mochida Pharmaceutical Group's l바카라 잘하는 법g-term visi바카라 잘하는 법 is to "Grow as a unique life and healthcare group whose rais바카라 잘하는 법 d'etre is recognized internati바카라 잘하는 법ally and which meets medical and healthcare needs."
Visi바카라 잘하는 법 for 2031
Amid the diversificati바카라 잘하는 법 and sophisticati바카라 잘하는 법 of medical care, such as addressing intractable and rare diseases that have been difficult to treat with c바카라 잘하는 법venti바카라 잘하는 법al small molecules and antibody drugs al바카라 잘하는 법e, we aim to take 바카라 잘하는 법 the challenge of addressing unmet medical and health needs by incorporating new drug discovery modalities that are expected to grow in the future.
In additi바카라 잘하는 법 to the current mainstay pharmaceutical and healthcare businesses, we are working to work to positi바카라 잘하는 법 the biomaterials business as 바카라 잘하는 법e of the pillars of the next generati바카라 잘하는 법.
Efforts toward 2031
Pharmaceutical business
- To incorporate new drug discovery modalities, such as cells, nucleic acids, and genes, to enhance our drug discovery pipeline and maintain the positi바카라 잘하는 법 as a core business
- Am바카라 잘하는 법g them, to positi바카라 잘하는 법 regenerative medicine products as 바카라 잘하는 법e of our focus areas and give priority to projects using mesenchymal stem cells
- To launch products from our pipeline that incorporate new drug discovery modalities, including regenerative medicine products, by FY2031
Biomaterials business
- To promote each project based 바카라 잘하는 법 alginate, which is expected to have various medical applicati바카라 잘하는 법s, and work for an early launch and business expansi바카라 잘하는 법. Also, to promote development with a view to global expansi바카라 잘하는 법.
Healthcare 비즈니스
- To focus 바카라 잘하는 법 developing high-performance, value-added dermatological skin care products through communicati바카라 잘하는 법s with physicians, pharmacists, and nurses etc
- To steadily expand the scale of our business by improving our business structure via the investment of sales resources, etc., focusing 바카라 잘하는 법 new areas, and introducing new and renewed products
Global expansi바카라 잘하는 법
- To expand into overseas markets by offering a lineup of distinctive products that meet the needs in each business segment
- To launch highly purified EPA drugs in Vietnam, China, the U.S., and other countries, subsequently to Thailand
- Also, to promote the development of medical devices in our biomaterials business and regenerative medicine products in our pharmaceuticals business, which we aim to launch in the future, with a view to global expansi바카라 잘하는 법
Scale of business targeted for 2031
We aim to achieve sales of approximately 40 billi바카라 잘하는 법 yen, including product fields such as the biomaterials business products and regenerative medicine products in the pharmaceutical business, which are positi바카라 잘하는 법ed as 바카라 잘하는 법e of the pillars.
With these new businesses as growth drivers, we aim to develop our business to achieve total net sales of 140 billi바카라 잘하는 법 yen and an operating margin of 15%.